Login / Signup

RIFLE: a Phase II trial of stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer.

Kun WangYajie ChenZhiyuan ZhangRuiyan WuMenglong ZhouWang YangJuefeng WanLijun ShenHui ZhangYan WangXu HanJiazhou WangZhen ZhangFan Xia
Published in: Gastroenterology report (2023)
NCT04948034 (ClinicalTrials.gov).
Keyphrases
  • metastatic colorectal cancer
  • early stage
  • locally advanced
  • brain metastases
  • radiation therapy
  • radiation induced
  • open label
  • small cell lung cancer
  • rectal cancer
  • placebo controlled